Navigation Links
Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
Date:3/4/2008

nt, Vermillion is granted exclusive

rights to the biomarker panel.

Ovarian Cancer Diagnostic Test Progress

-- Received the distinguished Society for Gynecologic Oncologists' (SGO)

Basic Science Poster Award for its abstract, "Prospective independent

validation of a marker panel for distinguishing benign from malignant

pelvic masses." The abstract, which demonstrated that the Company's

Ovarian Tumor Triage Test correctly identified 84 percent of ovarian

cancer cases, compared to only 33 percent identified using standard

diagnosis methods without the test, was presented at the SGO 38th

Annual Meeting on Women's Cancer last year in San Diego.

-- Completed enrollment of 550 patients at 27 medical centers in a

clinical trial to evaluate Vermillion's Ovarian Tumor Triage Test to

differentiate women with ovarian cancer from women with benign pelvic

masses.

-- Presented seven studies at the European Society for Gynecologic

Oncology meeting describing advancements in Vermillion's ovarian cancer

diagnostic program.

-- Data showed that Vermillion's panel of ovarian cancer protein

biomarkers in combination with CA-125 could more accurately identify

early-stage ovarian cancer than could CA-125 alone.

-- Data demonstrated that Vermillion's ovarian cancer biomarker panel

could accurately and with statistical significance predict women with

ovarian cancer who had good prognosis from those who did not. The study

used Kaplan-Meier analysis to show that women with a low panel score

were significantly more likely to survive than women with high scores,

independent of the stage of the disease.

Corporate Developments

-- Renewed a long-standing collaboration with Johns Hopkins University on

the development of novel biomarkers that can be applied towar
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Access Highlighted in Recent BusinessWeek Article
11. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Madison, WI (PRWEB) April 17, 2015 ... provide sales and marketing support for the powerful ... at the Chemical Genomics Center at the Lankenau ... LCGC’s mission is to measurably improve successful ... to HTS, by offering rare, drug-like libraries available ...
(Date:4/16/2015)... OSAKA, Japan , April 16, 2015 ... of Kyoto University and Takeda Pharmaceutical Company Limited ... to develop clinical applications of induced pluripotent stem ... mellitus, neurological disorders and cancer immunotherapy. The "Takeda-CiRA ... designed to expedite multiple research projects for drug ...
(Date:4/16/2015)... CA (PRWEB) April 16, 2015 Cytokinetics, ... to report first quarter results on Thursday, April 30, ... Cytokinetics’ senior management will host a conference call at ... results and the company’s outlook for the future. , ... be accessed from the homepage and in the Investor ...
(Date:4/16/2015)... 16, 2015 Proove Biosciences , ... of BIO Contest for the 2015 BIO International ... 2015 BIO International Convention will take place June 15-18 ... the Buzz of BIO contest, industry leaders will be ... at the conference. The community voting period began on ...
Breaking Biology Technology:BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3
... A team of nanotechnology researchers from the University ... force microscopy to determine the nanoscale frictional characteristics ... for these very different materials. Friction across ... atomic layers decreases, all the way down to ...
... (NIST) have built and tested a device for trapping electrically ... at once with the most versatile control of any trap ... to systematically scale up from traps that hold a few ... can process many ions simultaneously, with the ultimate goal of ...
... ... to devise an energy independence plan that goes beyond OCS drilling and that includes ... , ... (PRWEB) April 1, 2010 -- Responding to President Obama,s Decision to Open the East ...
Cached Biology Technology:Nanotechnologists reveal the frictional characteristics of atomically thin sheets 2NIST racetrack ion trap is a contender in quantum computing quest 2Responding to OCS Drilling Decision, Advocacy Group Challenges President to "Get Serious" About Energy Independence and Security 2
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces its ... of the products featured in 2015 "I Want That" ... PM EST on the DIY Network.   ... Vegas , site of the 2015 International CES ...
(Date:3/17/2015)... SAN DIEGO , March 17, 2015 /PRNewswire/ ... and emotion analytics software, today announced general availability ... on-demand web service for the analysis of facial ... they experience advertising, media content, products and services. ... customer attention, engagement and sentiment - as derived ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... Scientists using revolutionary new technology developed at The University ... life so far. Using a scientific technique known ... have been able to date chemical fossils discovered in ... that these fossil steroids, remnants of a type of ...
... was uncovered in London in August 2006, the Department ... to to find ways to not only detect liquids ... out what those liquids are. Now, S&T-sponsored scientists at ... They have successfully tested a liquid explosive detection ...
... work in animals showed limited activity when statins were ... in the February issue of Cancer Prevention Research ... Research. Statins, sold under brand names like ... and prevent heart disease, and prominent cardiologists almost universally ...
Cached Biology News:Engineering technology pinpoints earliest signs of animal life 2Good liquid, bad liquid 2Statin therapy ineffective in breast cancer prevention 2
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
...
Mouse monoclonal antibody raised against a partial recombinant WDR5. NCBI Entrez Gene ID = WDR5...
Biology Products: